Finding a crystal form is only the first step; evaluating its potential for real-world development is critical. Crystal Pharmatech utilizes a complete, proven evaluation system to assess the developability of your polymorphs, salts, and co-crystals, identifying potential risks early in the process.
We utilize advanced characterization methods to reveal the fundamental properties of your API.
Deploying XRPD, DSC, TGA, DVS, and PSD to provide a complete map of solid-state properties.
Revealing kinetic and thermodynamic stability alongside complex inter-form transformation relationships.
Accurately measuring solubility, hygroscopicity, and flowability to ensure material handling efficiency.
Rigorously testing the API to ensure it is viable for pharmaceutical processing and formulation stability.
Evaluating particle attributes and excipient compatibility to prevent manufacturing bottlenecks.
Assessing formulation stability and dissolution rates to confirm therapeutic potential.
Generating data that directly informs your downstream formulation and form control strategies.
Subscribe to be the first to get the updates!
